Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin Gel for Periodontitis in Smokers
NCT06653231Phase 1Completed
- Sponsor
- Cairo University
- Start
- Nov 2024
- Primary completion
- Feb 2025
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of curcumin in periodontitis (2 arms), sponsored by Cairo University. Primary endpoints: Probing Pocket Depth at 45 days and Clinical Attachment Level at 45 days. Started Nov 2024; status: completed.
02
Drugs
curcumin
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT06653231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06653231.